1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naive B cells

被引:62
|
作者
Geldmeyer-Hilt, Kerstin [1 ]
Heine, Guido [1 ,2 ]
Hartmann, Bjoern [1 ]
Baumgrass, Ria [2 ]
Radbruch, Andreas [2 ]
Worm, Margitta [1 ]
机构
[1] Charite, Allergie Ctr Charite, CCM, Klin Dermatol & Allergol, D-10117 Berlin, Germany
[2] Deutsch Rheuma Forschungszentrum Berlin, D-10117 Berlin, Germany
关键词
Vitamin D; Calcitriol; Vitamin D receptor; NF-kappa B; Naive B cells; VITAMIN-D-RECEPTOR; DOWN-REGULATION; P50; SUBUNIT; GENE; LYMPHOCYTES; PROMOTER; SUBPOPULATIONS; RESPONSES; DEFECTS;
D O I
10.1016/j.bbrc.2011.03.078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1 alpha,25-dihydroxyvitamin D-3 (calcitriol), the bioactive metabolite of vitamin D, modulates the activation and inhibits IgE production of anti-CD40 and IL-4 stimulated human peripheral B cells. Engagement of CD40 results in NF-kappa B p50 activation, which is essential for the class switch to IgE. Herein, we investigated by which mechanism calcitriol modulates NF-kappa B mediated activation of human naive B cells. Naive B cells were predominantly targeted by calcitriol in comparison with memory B cells as shown by pronounced induction of the VDR target gene cyp24a1. Vitamin D receptor activation resulted in a strongly reduced p105/p50 protein and mRNA expression in human naive B cells. This effect is mediated by impaired nuclear translocation of p65 and consequently reduced binding of p65 to its binding site in the p105 promoter. Our data indicate that the vitamin D receptor reduces NF-kappa B activation by interference with NF-kappa B p65 and p105. Thus, the vitamin D receptor inhibits costimulatory signal transduction in naive B cells, namely by reducing CD40 signaling. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:699 / 702
页数:4
相关论文
共 50 条
  • [21] 1,25-Dihydroxyvitamin D3 inhibits lipopolysaccharide-induced immune activation in human endothelial cells
    Equils, O
    Naiki, Y
    Shapiro, AM
    Michelsen, K
    Lu, D
    Adams, J
    Jordan, S
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 143 (01): : 58 - 64
  • [22] 1,25-DIHYDROXYVITAMIN D3 RECEPTORS IN HUMAN-LEUKOCYTES
    PROVVEDINI, DM
    TSOUKAS, CD
    DEFTOS, LJ
    MANOLAGAS, SC
    SCIENCE, 1983, 221 (4616) : 1181 - 1182
  • [23] 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice
    Xuewei Li
    Jie Liu
    Yingzhe Zhao
    Ning Xu
    E. Lv
    Chunzeng Ci
    Xiangling Li
    BMC Nephrology, 23
  • [24] PRODUCTION OF 1,25-DIHYDROXYVITAMIN D3 IN SKIN
    不详
    NUTRITION REVIEWS, 1986, 44 (09) : 299 - 300
  • [25] ENTEROHEPATIC PHYSIOLOGY OF 1,25-DIHYDROXYVITAMIN D3
    KUMAR, R
    NAGUBANDI, S
    MATTOX, VR
    LONDOWSKI, JM
    JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (02): : 277 - 284
  • [26] Tyrosine kinase activation in muscle cells by the steroid hormone 1,25-dihydroxyvitamin D3
    de Boland, AR
    Buitrago, C
    BONE, 2001, 29 (03) : 304 - 304
  • [27] Regulation of the porcine 1,25-dihydroxyvitamin D3-24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 and parathyroid hormone in AOK-B50 cells
    Zierold, C
    Reinholz, GG
    Mings, JA
    Prahl, JM
    DeLuca, HF
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 381 (02) : 323 - 327
  • [28] Down-regulation of NF-κB signals is involved in loss of 1α,25-dihydroxyvitamin D3 responsiveness
    Bao, Bo-Ying
    Ting, Huei-Ju
    Hsu, Jong-Wei
    Yasmin-Karim, Sayeda
    Messing, Edward
    Lee, Yi-Fen
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 120 (01): : 11 - 21
  • [29] 1,25-Dihydroxyvitamin D3 Promotes a Sustained LPS-Induced NF-κB-Dependent Expression of CD55 in Human Monocytic THP-1 Cells
    Izban, Michael G.
    Nowicki, Bogdan J.
    Nowicki, Stella
    PLOS ONE, 2012, 7 (11):
  • [30] 1,25-Dihydroxyvitamin D3 alleviates salivary adenoid cystic carcinoma progression by suppressing GPX1 expression through the NF-κB pathway
    Huang, Zhiquan
    Liu, Yeqing
    Huang, Zixian
    Li, Haifeng
    Gan, Xiangfeng
    Shen, Zhuojian
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (03) : 1271 - 1279